Showing results (81-90 of 160) with videos related to
Sort By:
Pageof 16
Immunogenetics|September 2, 2000
Molecular cloning of the C6A form cDNA of the mouse sixth complement component: functional integrity despite the absence of factor I modulesJ X Yu, B M Bradt, N R CooperPhysical Review Letters|October 3, 2001
Quantum phases of vortices in rotating Bose-Einstein condensatesN R Cooper, N K Wilkin, J M GunnThe Journal of Clinical Investigation|January 1, 1984
Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serumJ T Mayes, R D Schreiber, N R CooperJournal of Virology|May 1, 1986
Purification of the Epstein-Barr virus/C3d complement receptor of human B lymphocytes: antigenic and functional properties of the purified proteinG R Nemerow, M F Siaw, N R CooperJournal of Immunology (Baltimore, Md. : 1950)|January 1, 1979
Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertaseA T Sobel, N R Cooper, R D SchreiberThe Journal of Experimental Medicine|August 1, 1974
Formation and biologic role of polyoma virus-antibody complexes. A critical role for complementM B Oldstone, N R Cooper, D L LarsonThe Journal of General Virology|December 1, 1996
Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infectionM L Roberts, A T Luxembourg, N R CooperThe Journal of Clinical Investigation|March 1, 1975
Studies on human plasma C1 inactivator-enzyme interactions. II. Structural features of an abnormal C1 inactivator from a kindred with hereditary angioneurotic edemaP C Harpel, T E Hugli, N R CooperThe Journal of Biological Chemistry|May 15, 2001
Characterization of a novel proapoptotic caspase-2- and caspase-9-binding proteinE Bonfoco, E Li, F Kolbinger, et al.The Journal of Clinical Investigation|November 1, 1982
Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complementG R Nemerow, F C Jensen, N R CooperPageof 16